Hospital Arnau de Vilanova (Valencia) Servicio de Oncologia
Valencia, Spain
General hospital in Valencia
Carrer de Sant Clement, 12, 46015 València, Valencia
About Hospital Arnau de Vilanova (Valencia) Servicio de Oncologia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
9
Genentech, Inc.
1
Clinical Trials at Hospital Arnau de Vilanova (Valencia) Servicio de Oncologia
During the past decade, Hospital Arnau de Vilanova (Valencia) Servicio de Oncologia conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on
average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2012-05-17
2020-02-19
Completed
2,577
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
2012-06-01
2019-09-20
Completed
1,436
ASPET Study: An Observational Study of Tarceva (Erlotinib) in First Line in Patients With Advanced Non-Small Cell Lung Cancer Harbouring EGFR Activating Mutations
2013-12-30
2017-06-20
Completed
144
A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI)
2014-11-12
2017-03-13
Completed
334
A Study to Develop Predictive and Prognostic Tools for Optimizing Therapy With Bevacizumab Frontline Cancer Therapy in Participants With HER 2-Negative Aggressive Metastatic Breast Cancer
2015-12-09
2018-12-03
Completed
111
A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine in Combination With Atezolizumab or Atezolizumab-Placebo in Participants With Human Epidermal Growth Factor-2 (HER2) Positive Locally Advanced or Metastatic Breast Cancer (BC) Who Received Prior Trastuzumab and Taxane Based Therapy
2016-09-26
2020-02-06
Completed
202
A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet Chemotherapy
2017-09-11
2023-03-20
Active, not recruiting
453
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Arnau de Vilanova (Valencia) Servicio de Oncologia"
#1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "SOLTI Breast Cancer Research Group" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Hospital Arnau de Vilanova (Valencia) Servicio de Oncologia
According to Clinical.Site data, the most researched conditions in "Hospital Arnau de Vilanova (Valencia) Servicio de Oncologia" are
"Breast Cancer" (3 trials), "Breast Neoplasms" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Locally Advanced or Metastatic Breast Cancer" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Hospital Arnau de Vilanova (Valencia) Servicio de Oncologia" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Arnau de Vilanova (Valencia) Servicio de Oncologia
Most popular intervention types in "Hospital Arnau de Vilanova (Valencia) Servicio de Oncologia" are "Drug" (9 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Docetaxel" (4 trials), "Paclitaxel" (4 trials), "Placebo" (3 trials), "Atezolizumab" (2 trials) and "Pertuzumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Arnau de Vilanova (Valencia) Servicio de Oncologia
The vast majority of trials in "Hospital Arnau de Vilanova (Valencia) Servicio de Oncologia" are
9 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Hospital Arnau de Vilanova (Valencia) Servicio de Oncologia
Currently, there are NaN active trials in "Hospital Arnau de Vilanova (Valencia) Servicio de Oncologia".
undefined are not yet recruiting,
1 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Hospital Arnau de Vilanova (Valencia) Servicio de Oncologia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Arnau de Vilanova (Valencia) Servicio de Oncologia, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".